CardXX Receives Order From JP Laboratories for SIRAD Cards; SIRAD Cards Are an Important Tool in the War Against Terrorism
2005年5月3日 - 10:00PM
ビジネスワイヤ(英語)
CardXX, Inc. (Pink Sheets: CXCQ) a leading provider of advanced
electronics packaging solutions including smart cards and RFID
devices today announced that it has received an initial test
purchase order for 2,000 SIRAD(TM) radiation dosimeter cards from
New Jersey-based JP Laboratories, Inc. SIRAD(TM) is an abbreviation
for Self-indicating, Instant Radiation Alert Dosimeter. The
SIRAD(TM) cards are user-friendly, low-cost, wearable, and
disposable radiation dosimeters for monitoring high dosages of
ionizing radiations. SIRAD cards are always active and ready to
use, enabling police officers, firefighters, and emergency medical
personnel to measure their radiation exposure while dealing with
the aftermath of a "dirty bomb" attack or nuclear explosion. When
asked about the purchase order, Phil Worack of CardXX commented:
"We're very pleased with this initial test order from JP
Laboratories, for SIRAD(TM) cards. Most importantly, both we and JP
Laboratories believe that SIRAD(TM) cards can be an important tool
for Homeland Security first responders in the combating of
terrorism, and dealing with the widespread effects of 'dirty bomb'
attacks." About CardXX Colorado-based CardXX has developed patented
technologies to securely encapsulate electronics into smart cards
and other portable devices or form factors. CardXX partnered with
Spyrus to engineer the first smart card to receive certification
from the National Institute of Standards and Technology (NSIT) for
Overall Level 3 compliance, including Physical Security with the
Federal Information Processing Standard (FIPS) 140 -- Security
Requirements for Cryptographic Modules. The CardXX process offers
the following unique advantages: -- Injected thermoset polymer
encapsulates and protects all electronic elements completely and
securely. -- Low-temperature and low-pressure process prevents
damage to delicate electronics and improves manufacturing yield. --
Superior heat resistance and chemical resistance protects against
physical and chemical attacks. -- Physical access to chip
electronics is difficult to obtain without severe damage or
destruction of chip. About JP Laboratories New Jersey-based JP
Laboratories is a product research and development firm that is
active in the development of radiation sensitive devices and
products for combating terrorism, including the companies
SIRAD(TM). SIRAD's development was first funded by a SBIR contract
from the U.S. Naval Sea System Command and from past two years by
Technical Support Working Group (TSWG) with funds from the U.S.
Departments of Defense, Justice, Homeland Security and State. The
forward-looking statements contained herein are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those reflected in the forward-looking statements.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect management's analysis
only as of the date hereof. The company undertakes no obligation to
publicly revise these forward-looking statements to reflect events
or circumstances that arise after the date thereof. Readers should
carefully review the risks described in other documents the company
files from time to time with the Securities and Exchange
Commission, including Quarterly Reports and Current Reports on Form
8-K. SIRAD is a trade mark of JP Laboratories, Inc., U.S. Patent
5,420,000 and other patents pending.
Cardxx (PK) (USOTC:CXCQ)
過去 株価チャート
から 10 2024 まで 11 2024
Cardxx (PK) (USOTC:CXCQ)
過去 株価チャート
から 11 2023 まで 11 2024
Real-Time news about Cardxx Inc (PK) (その他OTC): 0 recent articles
その他のCardXX, Inc.ニュース記事